Trials
1 active
4 in total · 1 in the EU
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Placebo administered by a single intravenous (IV) dose followed by subcutaneous (SC) doses at 2 hours (+10 hours) of the IV dose completion and then 2 times per week up to Day 21.”In the company’s words, NCT05065216 on ClinicalTrials.gov
- Tested for
- Acute Stroke, Ischemic Stroke, Stroke
- Main trialPhase 2/3
- “This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limited treatment options. Participants who have or will receive mechanical thrombectomy (MT) are not eligible for participation. Additionally, participants who have received fibrinolytics are excluded unless they experience a persistent neurological deficit of moderate severity six or more hours after…”In the company’s words, NCT05065216 on ClinicalTrials.gov
Other drugs for Acute Stroke
- Neuroncell-EXCytopeutics Sdn. Bhd. · Phase 2/3
- CenvacibartRegeneron · Phase 3
- REGN9933Regeneron · Phase 3
- SP-8203Shin Poong Pharmaceutical Co. Ltd. · Phase 3
- SHPL-49Shanghai Hutchison Pharmaceuticals Limited · Phase 3
- RhTNK-tPACSPC · Phase 3
Coming up1
- DecPhase 2/3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2/3Recruiting | Dec 2026 | Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) | |
| Phase 2Completed | 23 Jan 2020 | Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke | |
| Phase 2Completed | 16 Mar 2022 | Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX) | |
| Phase 1Completed | 21 Jul 2019 | Study to Assess PK, Safety and Tolerability in Patients With DM and CKD |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026